In vitro susceptibilities of feline and canine Escherichia coli and Pseudomonas spp. isolates to ticarcillin and ticarcillin–clavulanic acid

Abstract

Ticarcillin-clavulanic acid has reasonable in vitro efficacy against canine and feline E. coli, and canine Pseudomonas spp. isolates. However, decisions to use this drug therapeutically must be made on prudent considerations to minimise selection for bacterial resistance.

In this issue – May 2013

“…The authors of the first paper this issue stress the care that should be taken to minimise the possibility of resistance when using antimicrobials that are not registered for veterinary use …”

“…This study reports on results of in vitro susceptibility testing of bacterial isolates collected from infections with E. coli and Pseudomonas spp. for susceptibility to T/C and to ticarcillin alone …”